Laxido Mini (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Polyethylene glycol 3350 is a large, non‑absorbable polymer that draws water into the colon by osmosis. The retained water softens the fecal mass and expands its volume, stimulating peristalsis and facilitating the passage of stool without being metabolized or absorbed into the bloodstream.

The dose of Laxido Mini is individualized and set by the prescribing healthcare professional based on the patient’s age, condition, and therapeutic goal. The prescriber determines the appropriate volume and frequency, and patients should follow the specific instructions provided on the prescription label.

Safety of Laxido Mini during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this product to weigh potential benefits against any possible risks.

To order Laxido Mini, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Laxido Mini contains polyethylene glycol 3350 combined with electrolytes, offering effective bowel cleansing with a lower risk of significant electrolyte loss compared with some sodium‑based laxatives. Its oral solution format allows easy dose adjustment, and it is generally well tolerated, making it comparable to other PEG‑based preparations such as Movicol or MiraLAX.

Laxido Mini should be stored at ambient temperature, below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain stability and potency.

Laxido Mini is supplied as an oral solution. The prescribed volume is mixed with a specified amount of water or other clear fluid, shaken gently, and consumed as directed by the prescriber. It is typically taken with a full glass of water to aid distribution throughout the gastrointestinal tract.

Serious risks include severe dehydration, marked electrolyte disturbances such as hypernatremia or hypokalemia, and allergic reactions that may present as rash, swelling, or difficulty breathing. Patients should seek immediate medical attention if they experience persistent diarrhea, dizziness, or any signs of an allergic response.

Laxido Mini should be avoided in individuals with known hypersensitivity to polyethylene glycol or any of its components, in patients with severe renal impairment, intestinal obstruction, or perforated bowel, and in those with acute inflammatory bowel disease flare-ups unless specifically directed by a physician.